Got it ...
"Patients in the high-dex group received Dex 40 mg days 1-4, 9-12, and 17-20 PO every 28 days. Patients in the low-dex group received Dex 40 mg days 1, 8, 15, and 22 PO every 28 days."
So ... both groups received 40mg of Dex, but the high-dex group it 12 out of 28 days whereas the low-dex group received it only 4 out of 28 days.
Very useful information, in my opinion, for future treatment of myeloma using Rev/Dex.
Regards,
Craig Persel